Next Article in Journal
Heterocycles in Peptidomimetics and Pseudopeptides: Design and Synthesis
Next Article in Special Issue
Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines
Previous Article in Journal
Receptor and Channel Heteromers as Pain Targets
Previous Article in Special Issue
Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation
Pharmaceuticals 2012, 5(3), 279-296; doi:10.3390/ph5030279

Notes on Article Versions

article html file updated23 January 2013 10:58 CET
article html file updated26 January 2013 08:24 CET
article html file updated29 January 2013 01:55 CET
article html file updated6 February 2013 06:15 CET
article html file updated7 February 2013 00:53 CET
article html file updated7 February 2013 10:46 CET
article xml file uploaded6 August 2013 16:02 CEST
article html file updated6 August 2013 16:02 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert